4th AACR-IASLC International Joint Conference
4th AACR-IASLC International Joint Conference on
LUNG CANCER TRANSLATIONAL SCIENCE: FROM THE BENCH TO THE CLINIC
January 4-7, 2016 – Hard Rock Hotel – San Diego, CA
Under the leadership of Margaret Foti, PhD, MD (hc), CEO of the American Association for Cancer Research (AACR), and Fred R. Hirsch, MD, CEO of the International Association for the Study of Lung Cancer (IASLC), we are thrilled to join in our fourth international conference on lung cancer research and treatment. The translational science featured at this conference will include the foundation of basic research that begins at the bench and continues through patient care in the clinic. This conference historically has attracted a diverse group of attendees (physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research), provided a venue to discuss recent advances, and established new collaborations. As in our past successful conferences, sessions will range in topics spanning immunotherapy, prevention and screening, epigenetics, molecular targets, genetics, drug resistance, clinical trials, patient advocacy, and more. This conference is not only a dynamic collaboration of the AACR and the IASLC, two organizations committed to the study of cancer, but also a dynamic collaboration of the many individuals charged with the study and treatment of this disease.
Continuing Medical Education (CME) Activity-AMA PRA Category 1 CreditsTM available.